6-Ethyl-2,10,10-trimethyl-1-oxaspiro[4.5]deca-3,6-diene
Common Name: |
6-Ethyl-2,10,10-trimethyl-1-oxaspiro[4.5]deca-3,6-diene |
IUPAC Name: |
10-ethyl-2,6,6-trimethyl-1-oxaspiro[4.5]deca-3,9-diene |
Molecular Formula: |
C12H18O3 |
SMILES: |
CCC1=CCCC(C12C=CC(O2)C)(C)C |
Inchi: |
1S/C14H22O/c1-5-12-7-6-9-13(3,4)14(12)10-8-11(2)15-14/h7-8,10-11H,5-6,9H2,1-4H3 |
Inchi Key: |
NHJSLVJXXDHDRV-UHFFFAOYSA-N |
Cas No: |
79893-63-3 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
0 |
Name |
Value |
Molecular Weight (g/mol) |
210.27 |
Mass (g/mol) |
206.167 |
Molar Refractivity |
58.70 |
Net Charge |
|
HBD |
|
HBA |
3 |
Rt Bonds |
7 |
Rings |
2 |
TPSA |
27.69 |
Hetero Atoms |
1 |
Heavy Atoms |
15 |
Aromatic Heavy Atoms |
6 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
272.00 to 274.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.01 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.50 |
LogP |
3.857 |
iLOGP |
2.62 |
XLOGP3 |
1.81 |
WLOGP |
2.06 |
MLOGP |
1.66 |
ESOL Log S |
-2.12 |
ESOL Solubility (mg/ml) |
1.6 |
ESOL Solubility (mol/l) |
0.008 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-2.01 |
Ali Solubility (mg/ml) |
2.05 |
Ali Solubility (mol/l) |
0.01 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-3.66 |
Silicos-IT Solubility (mg/ml) |
0.05 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-6.30 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.966 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.832 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
0 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |